Novel drug combination for the treatment of colon and breast cancers
Overview of innovation
The innovation is the rational combination of ezetimibe and curcumin for the treatment of colon cancer- which means one can apply a cancer therapeutic, orally. This would have significant value to the African population and solve key issues like the packaging and distribution of chemotherapeutic medicines.
This technology has application across the globe, with the hope that it will improve the lives of millions of inhabitants in the developing world.
Type of Intellectual Property protection
Patent
Innovation Opportunity Type
Investment
Partnership
Industry
Human health and social work activities
Pharmaceuticals and Biopharmaceuticals
Human health activities
Technology Readiness Level
TRL 5 – Prototype tested in a controlled environment